{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:03:43Z","timestamp":1773291823930,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1124\/jpet.112.192609","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T06:35:51Z","timestamp":1329892551000},"page":"510-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Ca2+ Channel Activators Reveal Differential L-Type Ca2+ Channel Pharmacology between Native and Stem Cell-Derived Cardiomyocytes"],"prefix":"10.1016","volume":"341","author":[{"given":"Jiesheng","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiubo","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.192609_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00005344-199010000-00023","article-title":"Pertussis toxin-sensitive G-protein activation does not influence the response to Bay K8644 in embryonic chick myocytes","volume":"16","author":"Anderson","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.112.192609_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/clpt.2011.9","article-title":"Opportunities for use of human iPS cells in predictive toxicology","volume":"89","author":"Anson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.112.192609_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1476-5381.1985.tb08830.x","article-title":"Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells","volume":"85","author":"Barry","year":"1985","journal-title":"Br J Pharmacol"},{"issue":"Suppl 2","key":"10.1124\/jpet.112.192609_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-2828(87)80005-6","article-title":"Calcium-agonists","volume":"19","author":"Bechem","year":"1987","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.112.192609_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2009.07.026","article-title":"L-type Ca2+ current in ventricular cardiomyocytes","volume":"48","author":"Benitah","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.112.192609_bib6","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI27167","article-title":"The L-type calcium channel in the heart: the beat goes on","volume":"115","author":"Bodi","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.112.192609_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1540-8167.1999.tb00246.x","article-title":"Unitary current analysis of L-type Ca2+ channels in human fetal ventricular myocytes","volume":"10","author":"Chen","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/jpet.112.192609_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.RES.0000033988.13062.7C","article-title":"L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices","volume":"91","author":"Chen","year":"2002","journal-title":"Circ Res"},{"key":"10.1124\/jpet.112.192609_bib9","doi-asserted-by":"crossref","first-page":"H2257","DOI":"10.1152\/ajpheart.01335.2007","article-title":"Reduced effects of Bay K8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation","volume":"294","author":"Chen","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.112.192609_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s002100000219","article-title":"Kinetic effects of FPL 64176 on L-type Ca2+ channels in cardiac myocytes","volume":"361","author":"Fan","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.112.192609_bib11","series-title":"Calcium Antagonism in Heart and Smooth Muscle. Experimental Facts and Therapeutic Prospects","author":"Fleckenstein","year":"1983"},{"key":"10.1124\/jpet.112.192609_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pflugers Arch"},{"key":"10.1124\/jpet.112.192609_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0026-895X(25)10425-2","article-title":"A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes","volume":"31","author":"Hamilton","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.192609_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000080317.92718.99","article-title":"Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization","volume":"93","author":"He","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/jpet.112.192609_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.103.062182","article-title":"Cardiac ion channel effects of tolterodine","volume":"308","author":"Kang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.192609_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.69.2.292","article-title":"Calcium current depression in isolated human atrial myocytes after cessation of chronic treatment with calcium antagonists","volume":"69","author":"Le Grand","year":"1991","journal-title":"Circ Res"},{"key":"10.1124\/jpet.112.192609_bib17","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.112.192609_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","article-title":"The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes","volume":"61","author":"Peng","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.112.192609_bib19","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2011.0312","article-title":"Contractile properties of early human embryonic stem cell-derived cardiomyocytes: \u03b2-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy","author":"Pillekamp","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1124\/jpet.112.192609_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0022-3565(25)38225-X","article-title":"Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca2+ channel activators, Bay K8644 and FPL 64176","volume":"265","author":"Rampe","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.192609_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ddr.430330313","article-title":"Activators of voltage-dependent L-type calcium channels","volume":"33","author":"Rampe","year":"1994","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.112.192609_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0022-3565(25)39252-9","article-title":"Electrophysiologic and biochemical studies on the putative Ca++ channel blocker MDL 12,330A in an endocrine cell","volume":"243","author":"Rampe","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.192609_bib23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0024-3205(85)90001-3","article-title":"Modulation of calcium channel function by drugs","volume":"37","author":"Schramm","year":"1985","journal-title":"Life Sci"},{"key":"10.1124\/jpet.112.192609_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s003950170065","article-title":"L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation","volume":"96","author":"Skasa","year":"2001","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.112.192609_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1124\/jpet.112.192609_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(99)00329-5","article-title":"The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels","volume":"375","author":"Triggle","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.192609_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pa.27.040187.002023","article-title":"Calcium channel ligands","volume":"27","author":"Triggle","year":"1987","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.112.192609_bib28","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1096\/fj.09-145177","article-title":"Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells","volume":"24","author":"Xi","year":"2010","journal-title":"FASEB J"},{"key":"10.1124\/jpet.112.192609_bib29","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","article-title":"Serine residue in the IIIS5\u2013S6 linker of the L-type Ca2+ channel \u03b11C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists","volume":"275","author":"Yamaguchi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.192609_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.64.2.235","article-title":"Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5\u2013S6 linker of the L-type Ca2+ channel \u03b11C subunit (Cav1.2) in binding of dihydropyridines and action of Ca2+ channel agonists","volume":"64","author":"Yamaguchi","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.192609_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(25)24897-2","article-title":"Bepridil block of cardiac calcium and sodium channels","volume":"237","author":"Yatani","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.192609_bib32","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/jpet.112.192609_bib33","doi-asserted-by":"crossref","first-page":"H2312","DOI":"10.1152\/ajpheart.1997.273.5.H2312","article-title":"Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs","volume":"273","author":"Zhong","year":"1997","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.192609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:44:56Z","timestamp":1739983496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S002235652418175X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.192609","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ca2+ Channel Activators Reveal Differential L-Type Ca2+ Channel Pharmacology between Native and Stem Cell-Derived Cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.192609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}